Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (11)

2024

  1. Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply

    Rheumatology (Oxford, England), Vol. 62, Núm. 5, pp. e168-e169

  2. Early-onset recurrent panniculitis as a phenotype of NLRC4-associated autoinflammatory syndrome: Characterization of pathogenicity of the p.Ser445Pro NLRC4 variant

    Australasian Journal of Dermatology, Vol. 64, Núm. 2, pp. 260-267

2022

  1. Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome

    Journal of Clinical Immunology, Vol. 42, Núm. 7, pp. 1421-1432

  2. Correction to: Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome (Journal of Clinical Immunology, (2022), 42, 7, (1421-1432), 10.1007/s10875-022-01298-2)

    Journal of Clinical Immunology

  3. Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3

    Rheumatology (United Kingdom)

  4. First Description of Late-Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism

    Arthritis and Rheumatology, Vol. 74, Núm. 4, pp. 692-699

2020

  1. Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations

    Journal of Clinical Immunology, Vol. 40, Núm. 7, pp. 987-1000

2016

  1. Brief Report: Late-Onset Cryopyrin-Associated Periodic Syndrome Due to Myeloid-Restricted Somatic NLRP3 Mosaicism

    Arthritis and Rheumatology, Vol. 68, Núm. 12, pp. 3035-3041

  2. The inflammasome pathway in stable COPD and acute exacerbations

    ERJ Open Research, Vol. 2, Núm. 3

2014

  1. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response

    Nature Immunology, Vol. 15, Núm. 8, pp. 738-748